What is Dianthus Therapeutics's investing cash flow?

Dianthus Therapeutics (DNTH) reported investing cash flow of -$133.97M in Q1 2026.

How has Dianthus Therapeutics's investing cash flow changed year-over-year?

Dianthus Therapeutics's investing cash flow decreased by 1005.6% year-over-year, from $14.79M to -$133.97M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Dianthus Therapeutics DNTH Investing Cash Flow

Investing Cash Flow at other companies

Johnson & JohnsonJNJ

-$1.04B-250%

AmgenAMGN

-$716M-60.2%

Spyre Therapeutics, Inc.SYRE

$56.58M+92,856%

Kymera TherapeuticsKYMR

-$142.84M-394%

Protagonist TherapeuticsPTGX

$90.89M+196%

TG TherapeuticsTGTX

-$9.86M+23.7%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's investing cash flow?: Dianthus Therapeutics (DNTH) reported investing cash flow of -$133.97M in Q1 2026.
How has Dianthus Therapeutics's investing cash flow changed year-over-year?: Dianthus Therapeutics's investing cash flow decreased by 1005.6% year-over-year, from $14.79M to -$133.97M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.